BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36536497)

  • 1. Proteomics analysis of meclofenamic acid-treated small cell lung carcinoma cells revealed changes in cellular energy metabolism for cancer cell survival.
    Yanar S; Kasap M; Kanli A; Akpinar G; Sarihan M
    J Biochem Mol Toxicol; 2023 Apr; 37(4):e23289. PubMed ID: 36536497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of a nonsteroidal anti-inflammatory drug in combination with topotecan on small cell lung cancer cells.
    Yanar S; Kanli A; Kasap M; Bal Albayrak MG; Eskiler GG; Ozkan AD
    Mol Biol Rep; 2024 Jan; 51(1):145. PubMed ID: 38236451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of DJ-1 as a contributor to multidrug resistance in human small-cell lung cancer using proteomic analysis.
    Gao H; Niu Y; Li M; Fang S; Guo L
    Int J Exp Pathol; 2017 Apr; 98(2):67-74. PubMed ID: 28580701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the effect of meclofenamic acid on the proteome of LNCaP cells reveals changes in alternative polyadenylation and splicing machinery.
    Saglam BS; Kanli A; Yanar S; Kasap M; Akpinar G
    Med Oncol; 2022 Sep; 39(12):190. PubMed ID: 36071279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer.
    Udyavar AR; Hoeksema MD; Clark JE; Zou Y; Tang Z; Li Z; Li M; Chen H; Statnikov A; Shyr Y; Liebler DC; Field J; Eisenberg R; Estrada L; Massion PP; Quaranta V
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S1. PubMed ID: 24564859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis.
    Li L; Pan Y; Mo X; Wei T; Song J; Luo M; Huang G; Teng C; Liang K; Mao N; Yang J
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2519-2534. PubMed ID: 32648226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SILAC Quantitative Proteomics and Biochemical Analyses Reveal a Novel Molecular Mechanism by Which ADAM12S Promotes the Proliferation, Migration, and Invasion of Small Cell Lung Cancer Cells through Upregulating Hexokinase 1.
    Duan Q; Li D; Xiong L; Chang Z; Xu G
    J Proteome Res; 2019 Jul; 18(7):2903-2914. PubMed ID: 31117637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer.
    Ocak S; Friedman DB; Chen H; Ausborn JA; Hassanein M; Detry B; Weynand B; Aboubakar F; Pilette C; Sibille Y; Massion PP
    J Thorac Oncol; 2014 Mar; 9(3):324-36. PubMed ID: 24518087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomics of small cell lung carcinoma.
    Ziv T; Barnea E; Segal H; Sharon R; Beer I; Admon A
    Cancer Biomark; 2006; 2(6):219-34. PubMed ID: 17264394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of human small cell lung cancer tissues: up-regulation of coactosin-like protein-1.
    Jeong HC; Kim GI; Cho SH; Lee KH; Ko JJ; Yang JH; Chung KH
    J Proteome Res; 2011 Jan; 10(1):269-76. PubMed ID: 21047053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
    Byers LA; Wang J; Nilsson MB; Fujimoto J; Saintigny P; Yordy J; Giri U; Peyton M; Fan YH; Diao L; Masrorpour F; Shen L; Liu W; Duchemann B; Tumula P; Bhardwaj V; Welsh J; Weber S; Glisson BS; Kalhor N; Wistuba II; Girard L; Lippman SM; Mills GB; Coombes KR; Weinstein JN; Minna JD; Heymach JV
    Cancer Discov; 2012 Sep; 2(9):798-811. PubMed ID: 22961666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m
    Zhang Z; Zhang C; Yang Z; Zhang G; Wu P; Luo Y; Zeng Q; Wang L; Xue Q; Zhang Y; Sun N; He J
    J Hematol Oncol; 2021 Nov; 14(1):190. PubMed ID: 34758859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer.
    Han M; Dai J; Zhang Y; Lin Q; Jiang M; Xu X; Liu Q; Jia J
    Oncol Rep; 2012 Dec; 28(6):2233-8. PubMed ID: 22992788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.
    Sun Y; Shen W; Hu S; Lyu Q; Wang Q; Wei T; Zhu W; Zhang J
    J Exp Clin Cancer Res; 2023 Mar; 42(1):65. PubMed ID: 36932427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DLL3 is regulated by LIN28B and miR-518d-5p and regulates cell proliferation, migration and chemotherapy response in advanced small cell lung cancer.
    Huang J; Cao D; Sha J; Zhu X; Han S
    Biochem Biophys Res Commun; 2019 Jun; 514(3):853-860. PubMed ID: 31079917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer.
    Schneider BJ; Worden FP; Gadgeel SM; Parchment RE; Hodges CM; Zwiebel J; Dunn RL; Wozniak AJ; Kraut MJ; Kalemkerian GP
    Invest New Drugs; 2009 Dec; 27(6):571-8. PubMed ID: 19225720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line treatments of small-cell lung cancers.
    Baize N; Monnet I; Greillier L; Quere G; Kerjouan M; Janicot H; Vergnenegre A; Auliac JB; Chouaid C
    Expert Rev Anticancer Ther; 2017 Nov; 17(11):1033-1043. PubMed ID: 28849951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untargeted metabolomics and lipidomics identified four subtypes of small cell lung cancer.
    Zhang C; Shang X; Wang H
    Metabolomics; 2022 Dec; 19(1):3. PubMed ID: 36574156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Proteomic Analysis between Small Cell Lung Carcinoma (SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures for Malignancy in Lung Cancer.
    Fujii K; Miyata Y; Takahashi I; Koizumi H; Saji H; Hoshikawa M; Takagi M; Nishimura T; Nakamura H
    Proteomics Clin Appl; 2018 Nov; 12(6):e1800015. PubMed ID: 29888431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles from non-neuroendocrine SCLC cells promote adhesion and survival of neuroendocrine SCLC cells.
    Jimenez L; Stolzenbach V; Ozawa PMM; Ramirez-Solano M; Liu Q; Sage J; Weaver AM
    Proteomics; 2024 Jun; 24(11):e2300030. PubMed ID: 37926756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.